1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
5.1. Covid-19: Chemiluminescence Immunoassay Industry Impact
5.2. Chemiluminescence Immunoassay Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Chemiluminescence Immunoassay Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Europe Chemiluminescence Immunoassay Market Players to deal with Covid-19 Pandemic Scenario
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Upsurge in demand for treatment monitoring and precautionary diagnosis
6.1.1.2. Growth in technological advancements in disease diagnosis and COVID19 pandemic
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Europe Chemiluminescence Immunoassay Market Revenue by Market Players
7.1.1.2. Europe Chemiluminescence Immunoassay Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product TypeSuppliers
7.1.3.2. List of End-users
8.1. Europe Chemiluminescence Immunoassay Market, by Component
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast
8.1.3. Software & Services
8.1.3.1. Market Revenue and Forecast
9.1. Europe Chemiluminescence Immunoassay Market, by Application
9.1.1. Cardiology
9.1.1.1. Market Revenue and Forecast
9.1.2. Therapeutic Drug Monitoring
9.1.2.1. Market Revenue and Forecast
9.1.3. Oncology
9.1.3.1. Market Revenue and Forecast
9.1.4. Endocrinology
9.1.4.1. Market Revenue and Forecast
9.1.5. Autoimmune Disease
9.1.5.1. Market Revenue and Forecast
9.1.6. Infectious Disease
9.1.6.1. Market Revenue and Forecast
9.1.7. Others
9.1.7.1. Market Revenue and Forecast
10.1. Europe Chemiluminescence Immunoassay Market, by End-user
10.1.1. Clinical Laboratories
10.1.1.1. Market Revenue and Forecast
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast
10.1.3. Pharmaceutical & Biotechnology Companies
10.1.3.1. Market Revenue and Forecast
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type
11.2.2. Market Revenue Forecast by Application
11.2.3. Market Revenue Forecast by End-user
12.1. F. Hoffmann-La Roche AG
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin
12.1.4. Recent Developments and Strategies
12.2. Siemens Healthineers
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin
12.2.4. Recent Developments and Strategies
12.3. Abbott Laboratories
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin
12.3.4. Recent Developments and Strategies
12.4. DiaSorin S.p.A.
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin
12.4.4. Recent Developments and Strategies
12.5. Ortho Clinical Diagnostics
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin
12.5.4. Recent Developments and Strategies
12.6. Immunodiagnostic Systems
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin
12.6.4. Recent Developments and Strategies
12.7. Beckman Coulter Inc.
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin
12.7.4. Recent Developments and Strategies
12.8. Inova Diagnostics, Inc.
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin
12.8.4. Recent Developments and Strategies
12.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin
12.9.4. Recent Developments and Strategies
12.10. Maccura Biotechnology Co., Ltd
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin
12.10.4. Recent Developments and Strategies
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
